Skip to content
OpenCapital
Get started

Boston Scientific BSX Cardiovascular — Other segment items

Other segment segments

MedSurg
$5M-16.7%

Similar metrics at other companies

Medtronic logo
MDTCardiovascular — Other segment items
-$1M+92.9%
Genpact logo
GFinancial Services — Other segment items
$67.63M+8.8%
FTI Consulting logo
FCNCorporate Finance — Other segment items
$23.12M+9.0%
Medtronic logo
MDTMedical Surgical — Other segment items
$5M+25.0%
Mirion Technologies logo
MIRMedical Segment — Other segment items
$39.3M-3.4%
Coty logo
COTYCorporate — Other segment items
$7.1M-95.7%

Other financials

Income statement

See full
Revenue$5.4B+7.5%
Gross profit$3.8B+12.4%
Operating income$1.2B+43.8%
Net income$907.0M+14.1%
EPS (diluted)$0.61+15.1%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total debt$659.0M-94.1%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$68.37B-56.0%
P/E18.6×-43.5×
P/S3.3×-5.1×

Profitability

See full
Gross margin69.9%+1.7pp
Operating margin19.8%+2.8pp
Net margin17.5%+4.0pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity0×-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's cardiovascular — other segment items.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's cardiovascular — other segment items?
Boston Scientific (BSX) reported cardiovascular — other segment items of $7M in Q1 2026.
How has Boston Scientific's cardiovascular — other segment items changed year-over-year?
Boston Scientific's cardiovascular — other segment items increased by 16.7% year-over-year, from $6M to $7M.
What is the long-term trend for Boston Scientific's cardiovascular — other segment items?
Over 3 years (2022 to 2025), Boston Scientific's cardiovascular — other segment items has grown at a 4.4% compound annual growth rate (CAGR), from $22M to $25M.
What does cardiovascular — other segment items mean?
This metric represents miscellaneous income or expense items specifically attributed to the cardiovascular business segment that are not classified under core operating categories like R&D or SG&A. It captures non-recurring or peripheral financial adjustments unique to the cardiovascular product line's operations.